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Background: Reconstruction of Charcot feet remains a surgical challenge. The goal of this study was to investigate
safety and clinical benefit from reconstruction of Charcot feet using an external fixator. There is limited valid data
regarding long-term outcomes for Charcot foot procedures.
Methods: In a retrospective study, 292 Charcot feet (282 patients) undergoing reconstructive procedures in our
clinic from 1996–2010 were included (93 female, 189 male, mean age 57.9 years). Average follow-up was
24.1 months. Exclusion criteria were previous major amputation on the same side. All patients underwent surgery
using a Hoffmann II external fixator for six to eight weeks with offloading. The fixator was then removed, and a
customized AFO with full weight bearing was applied for another 11 months. After one year, patients received
customized orthopedic shoes.
Results: Initial amputations were avoided. Patient activity improved significantly by more than 1 level (SD 0.67,
p < .001) according to the Hoffer activity score for lower limb amputees. The most common minor complication
was persistent or recurrent ulceration in 67 feet (23%). Secondary amputation (after failure of external fixation) was
required in only 12 patients (6.2%). Orthopedic shoes were used by approximately 34% of patients 18 months after
surgery.
Conclusions: Reconstructive surgery of Charcot feet using external fixation is a safe and economically feasible
procedure. Activity levels improved significantly by more than 1 level (p < 0.01), severe complications were rare,
and secondary amputation was required in only 12 patients (6.2%) of a high-risk patient population. Use of an
external fixator offers the advantage that all extraneous material is removed after six weeks; thus, there is no risk of
broken screws or plates and the associated potential complications.
Keywords: Charcot feet, Charcot neuropathy, Reconstructive surgery, Diabetes mellitus, External fixatorBackground
Published descriptions of neuropathic arthropathy by
Charcot initially appeared in 1868 [1]. Different types of
polyneuropathy are central to its development [2]. In
recent studies, an infectious etiology for the development
of Charcot neuropathy (CN) has been proposed [3].
Although diabetes mellitus is the most common cause
for CN in western and developing countries, there are
many other etiologies for its development, e.g. alcohol* Correspondence: ulrich_illgner@web.de
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unless otherwise stated.abuse, rheumatoid arthritis, toxicity (e.g. induced by
methotrexate), idiopathic, or as a result of leprosy or other
diseases [4]. “The interaction of several component factors
(diabetes, sensory-motor neuropathy, autonomic neur-
opathy, trauma, and metabolic abnormalities of bone)
results in an acute localized inflammatory condition that
may lead to varying degrees and patterns of bone destruc-
tion, subluxation, dislocation, and deformity “(International
consensus report [2]). The number of patients with diabetes
mellitus is rising in western and developing countries, most
likely with many undiagnosed patients [5]. The WHO states
347 million patients with diabetes mellitus worldwide
(WHO fact sheet no 312, updated Nov 2014 [6]).td. This is an Open Access article distributed under the terms of the Creative
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Table 1 A, B: Patient’s data and secondary diagnoses
Patients (n=) 282
Foot surgeries (n=) 292
Age (y) 57,9 (SD 10.16)
Male 189 (77.1%)
Female 93 (32.9%)
BMI 32,8 (19.9 -59.7, SD 6.9)
Diabetes type 1 37 (13.1%)
Diabetes type 2 207 (73.4%)





Coronary heart disease 54 (19.1%)
Peripheral vessel disease 53 (18.8%)
Alcohol abuse 9
Rheumatoid arthritis 9
Hereditary motosensoric neuropathy 2
M. von Recklinghausen 1
Idiopathic 17
Total 38
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mains a surgical challenge. Most cases exhibit atypical,
multidirectional destruction and instability, often com-
bined with major bone loss and ulceration with infec-
tion [7]. In addition, most patients have comorbidities
and suffer from diabetes mellitus, nephropathy, and/or
peripheral vascular disease. Longer operative duration,
hemoglobin A1c levels >7 mg/dl, and peripheral neur-
opathy elevate complication rates, especially regarding
wound healing and infections [8,9]. Infections with P.
aeruginosa in particular have been associated with poor
outcomes [7].
Various surgical approaches using internal, external,
or combined fixation techniques have been published.
However, valid long-term outcome studies with suffi-
cient patient numbers are lacking [10,11]. In a case
report, Facaros combined internal plate fixation with a
ring external fixator (i.e. Ilizarov) [12]. Grant reported
the long-term outcomes of 46 patients using the SF-36
questionnaire. These patients underwent various types
of surgery using either column beaming or external
fixation, with or without bone grafting. Amputation was
required in 4% of cases, and osteomyelitis occurred in
26%, but still, “none of the demographic variables was
statistically significantly associated with patient outcomes
as measured by the SF-36 and the patient satisfaction
survey” [11].
It is important to investigate outcome markers relevant
to patients. Ambulation and activity level are at first and
most important impaired when ulcers develop on the
foot. Usually these ulcers are located plantar at the sites
of most load bearing and most affection of CN. Offload-
ing and/or reconstruction surgery are standard treatment
options meaning that these patients cannot walk at all or
only in very limited matter. Because of the mostly bilat-
eral polyneuropathy and in most cases high elevated
BMI, many patients are not able to walk on crutches.
There is a high risk to become depend on foreign help
and wheelchairs. Social life seems nearly impossible and
consecutive complications (e.g. thrombosis, pneumonia)
can follow. Once an ulcer is healing there is a high rate of
recurrence and the whole problems restarts.
Charcot neuroarthropathy (CN) is a lifelong condition
with high rates of recurrence, and broken screws or plates
in particular can cause future ulceration. Amputation rates,
ability to walk (outside), need for orthotic devices, and re-
currence of ulceration and/or infection are the benchmarks
for a successful outcome in our opinion. Radiological re-
sults and fusion rates are also important for evaluation, but
they should not be considered outcome measures.
The goal of our study was to find out, if our proposed
treatment regimen with full weight bearing as early as
6 weeks after surgery leads to an improvement of activity
level and amputations can be kept at a low level.Methods
From 1996–2010, 292 feet (282 patients) were included in
this study (Table 1). Average follow-up was 24.1 months
(3–49 months). 288 patients underwent standard proce-
dures in that time, but six patients were excluded because
of incomplete reports. Medical records, including pre and
post-operative radiographs and information regarding
walking ability and use of orthotic devices, were examined
retrospectively in the year 2011 by the examination doctor
inspecting the worn orthotic devices or shoes and the
walking ability of the patients.
Activity level was measured during the controls using
the Hoffer score, which consists of 4 levels, activity level 0
means “non walker”, level 1 means “therapy walker”, level
2 “household walker” and level 3 “community walker”.
Exclusion criteria were arthrodesis of reconstructive
foot surgery without Charcot neuroarthropathy (CN),
and major amputation on the same side.
All patients gave formal consent to participate in this
study and all demands of the declaration of Helsinki
were fulfilled. The ethic committee of the University of
Muenster approved the study.
Surgery was performed in all stages of Eichenholtz, most
patients were in Eichenholtz stage II. We do not see
Eichenholtz stage I as a contra indication for surgery using
an external fixator. Indications for surgery included in-
stability of the tibio-calcaneal, talo-calcaneal (subtalar),
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total contact cast or AFO, exostoses causing skin ulcer-
ation, therapy-resistant ulceration, and/or osteomyelitis.
With the use of external fixation, reduction and stable
immobilization are possible without direct contact to the
affected area. When deformity was minimal and the tibio-
calcaneal joint was not affected (Sanders I-III), we used
Steinmann pins for reduction. The pins were regularly re-
moved after 6 weeks. Only is case of infection pins were
removed earlier and we did not let the pins stay in longer.
Patients wore an AFO with full weight bearing for a mini-
mum of 12 months. With an AFO, patients are able to re-
turn to work. Our goal for the patients was the ability to
walk in customized orthopedic shoes after 12 months.
When major edema and ulcerations were visible, the
joint was immobilized preoperatively in a cast. Systemic
(I.V.) antibiotics were given for major infections as soon
as possible according to culture and sensitivity tests.
The operation starts with a tenotomy of the Achilles ten-
don. Then we approached from the convex side of the af-
fected part of the foot. In severe deformities we performed a
bilaterally approach. Then debridement and resection of
infected ligaments, capsules, and/or exostoses followed. Un-
affected cancellous bone was saved and used as autologous
graft. Local antibiotics (Septopal® chains) were used in cases
of macroscopic infection. Steinmann pins with a central
thread were passed through the metatarsal heads, then into
the calcaneus and tibia and were stabilized by an external
double frame Hoffmann-II-Fixator (Figure 1).
In 265 cases, Hoffmann II external fixators, and in 17
patients, Steinmann pins were used for reduction. In
seven cases, reduction was performed after resection of
a metatarsal wedge. A cast for the lower limb was then
applied for 6 weeks. The pins were removed after
6 weeks, and patients were mobilized with full weight-
bearing in an interim AFO for a minimum of 12 months
once swelling was decreased. AFOs were made from car-
bon fibers, and after an average 3–4 months, swelling of
the feet decreased enough to require a second AFO.Figure 1 Reduction using a double-frame external fixator.12 months after surgery, customized orthopedic
shoes with a stiff sole, cushioned heel, retrocapital
rocker, bimalleolar cup (in severe cases with an arth-
rodesis cup), and smooth, diabetic insole were supplied.
At 6 and 12 weeks as well as 6 and 12 months, clinical
and radiologic examinations were performed to avoid
recurrence and check for skin lesions. Bony consolida-
tion and remineralization were documented with radio-
graphs. The goal of treatment is a plantigrade and
stable foot for ambulation. In our opinion, complete
consolidation of arthrodesis is not necessary; however,
a stable pseudarthrosis at least should be present.
The observed data were entered into a computerized
database (Microsoft Excel 2003) and statistically evaluated
using IBM SPSS Statistics Software for Windows Release
20.0.0 (2011, Chicago). Categorical variables are expressed
as frequency and percentage. Whereas continuous and or-
dinal variables are presented as mean ± SD. The Marginal-
Homogeneity-test was used to compare the difference
between two dependent ordinal variables (pre-op. vs. post-
op. Activity level). Differences were considered significant
at p < 0.05.
Results
292 feet (282 patients) were included in the study, with
189 male (77.1%) and 93 female (32.9%) patients (Table 1).
Polyneuropathy was present in all patients. Most patients
suffered from type 2 diabetes (73.4%) and type 1 diabetes
(13.1%). 38 patients exhibited polyneuropathy and Char-
cot neuroarthropathy from other causes (Table 1A, B).
Common secondary diagnoses were retinopathy with
an increased falling risk, hypertension, and nephropathy.
26% of type 2 diabetes patients also suffered from periph-
eral vascular disease (Table 1A, B).
Before surgery, ulcers were present in 184 patients
(63%). Ulceration recurred in 67 feet (23%).
All Types of Sanders were included. A combination of
Types II and III (Sanders) were most common. The
mid-foot was most commonly affected, and a combined
involvement was present in nearly all patients (therefore
percentage is more than 100%). Type II (76.9%) and III
(81.4%, classification of Sanders) were most common.
Type I showed the lowest rate of affection (34.1%).
Patients’ activity levels improved significantly (p < 0.001)
by 1.01 points with a standard deviation of 0.7 (Table 2).
Initial amputation was completely avoided. 24 months
after surgery, 87 patients (44.6%) were already able to
walk in customized orthopedic shoes and 88 (45.3%) in
AFOs. Only 6.1% of the patients had to be amputated
secondarily due to a failed first surgery and seven pa-
tients had died (Table 3).
Only 19.6% of the cases resulted in pseudarthrosis.
Other reasons for revisions were dehiscence (6.7%) and
infection (2.1%).
Table 2 Ability to walk pre- and post-operative
(according to the Hoffer activity level)





Drop out 46 32
Average level 1.13 (SD 0.81) 2.14 (SD 0.67)
Total feet 292 292 p < 0.001
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Charcot neuropathy is a severe chronic disease most
often due to diabetes mellitus, which remains a chal-
lenge for surgeons.
In this largest study investigating long-term outcomes
after Charcot foot reconstruction, the use of an external
fixator proved to be a safe and cost-effective procedure
with few severe complications.
Initial amputations were avoided completely, and the
foot was retained in 93.8% of cases overall (Table 3).
There is a debate about the cost and effectiveness of foot
reconstruction versus transtibial amputation and Gil
showed 2013 that the costs of reconstruction of Charcot
feet might be similar to transtibial amputation in prelim-
inary data [13]. In our opinion amputation should only
be performed, if there is no other choice to save the foot
and whenever possible partial amputations of the foot
should be performed. As mentioned in the Article of
Gil, too, rehabilitation after transtibial amputation and
especially problems concerning the stump can be chal-
lenging. Usually it takes a long time from surgery until
walking after transtibial amputation. We believe that fastTable 3 A) Surgery outcome and complications, B) use of
orthopedic devices
Pseudarthrosis 38 (19.6%)








Customized orthopedic shoes 87 (44.6%)
AFO 88 (45.3%)
Total 194 = 100%
Drop-out 88recovery after surgery and the ability to walk with full
weight bearing is essential for these high-risk patients.
In a prospective clinical study of 26 patients undergo-
ing mid-foot correction using external fixation, Pinzur
yielded 24 infection-free and ulceration-free, ambulating
patients. One patient died, and one required amputation
[14]. This is the only prospective study of Charcot feet
identified by our search; however, its scientific value is
limited by the small number of patients. In another pub-
lication Pinzur described in 2004 the outcome of surgical
versus accommodative treatment for Charcot of the mid-
foot; 63 patients underwent surgery (3 initial amputa-
tions) and out of these patients 5 patients (8.5%) had
amputation after failure of the salvage surgery [15]. Sur-
gery using a fixateur externe as salvage procedure for
osteomyelitis in 178 patients with Charcot Neuroarthro-
pahty was published by Pinzur in 2012; in 95.7% of the
patients the limb could be saved, three patients had to be
amputated [16].
In our study walking ability improved significantly
from activity class 1.13 before surgery to an average of
activity class 2.14. The activity class of 1.13 means that
most patients could not walk alone (without therapist)
at all or only single steps before the intervention. They
were mostly depended on help every day and were more
or less excluded from social life, as well. Being unable to
walk causes high cost for the care and transport of the
patients. After surgery patients were able to walk alone
inside and sometimes outside (Table 2). Walking ability
is extremely important for the cardiopulmonary health
of patients, and enables independent living. This is cost-
sparing, prevents falls and associated complications, and
integrates patients in society. Thus, we deemed this out-
come parameter as important and selected it for use in
the current study. Further clinical prospective studies
are needed to quantify the effect of walking ability to
survival rates, hospitalizations, dependence and costs of
care for these patients.
Use of the external fixator yielded a high fusion rate,
with only 19% resulting in unstable pseudarthrosis re-
quiring revision. The external fixator offers the advan-
tage that all foreign material is removed after six weeks,
and thus, cannot fracture or degrade and migrate within
the body. Broken remnants are often difficult to remove
and can result in internal pressure and ulceration in this
high-risk population. Because of the polyneuropathy, pa-
tients often do not even recognize shifted hardware;
thus, ulceration and infection are dangerous potential
complications. As previously mentioned, Charcot neur-
opathy is a lifelong condition, and this must be consid-
ered in planning the procedure.
We saw a high drop-out of 88 patients within 24 months
(Table 3). Our university clinic has been a centre for treat-
ing Charcot neuroarthropathy since the 1990s, therefore
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more than 120 km. That is why many patients are send in
critical situations or for surgery but do not usually come
regularly as outpatients for controls, if there are no major
problems. Another reason is that especially the patients
who were able to use a customized orthopedic shoe after
12 months did not come for further consultations, be-
cause they did see reason to travel a long distance without
major problems.
In most cases, different areas of the foot were affected
according to the Sanders classification, most commonly
the midfoot (Sanders II and III).
In patients without Diabetes mellitus most often alcohol
abuse and rheumatoid arthritis caused polyneuropathy
(Table 1B). That is a remarkable result as “Rheumatic
Charcot feet” rarely are described. Grear stated in his art-
icle that the orthopedic community has to be more aware
of the relationship of these two diseases 2013 [17]. Char-
cot feet due to idiopathic neuropathy represent another
entity, which just recently had been published and has not
been thoroughly investigated [18]. In our opinion, there
could be a high number of undiagnosed patients specific-
ally in the early stages of CN in patients without diabetes
mellitus, because many physicians combine Charcot neu-
roathropathy strictly to diabetes mellitus.
The rate of ulceration could be lowered from 184
(63%) to 67 feet with a recurrence/persistance (23%).
Limitations to this study are the high drop out of pa-
tients. Further a prospective trial comparing the out-
comes of internal and external fixation would give more
information.Conclusions
Reconstruction of Charcot feet showed to be a save and
cost-effective procedure. Severe complications were rare
with a low amputation rate. The activity level could be
improved significantly by more than 1 level.
Abbrevations
CN: Charcot neuroarthropathy; BMI: Body mass index.
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